Mindfulness Based Stress Reduction in Rheumatic Diseases

Stopped early

Conditions studied: Rheumatoid Arthritis, Psoriatic Arthritis, Scleroderma

In brief

This study will assess the mental health and clinical benefits of Mindfulness Based Stress Reduction (MBSR) in patients with rheumatic disease who have anxiety or depression. MBSR, an interactive form of meditation that includes gentle yoga, will be taught by a certified instructor over an eight-week period. Mental health surveys will be conducted within one month of the study start and end as well as mid-course. Clinical assessments will be conducted within one-month of the study start and end.

Key facts

Study ID

NCT03411057

Run by

Johns Hopkins University

People needed

5

Starts

2018-01-18

Expected to finish

2021-04-22

Last updated by the study team

2021-04-26

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Established patients in the Johns Hopkins Bayview Rheumatology clinic
• Rheumatoid Arthritis per the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) 2010 classification criteria
• Psoriatic Arthritis per the Classification Criteria for Psoriatic Arthritis (CASPAR) or physician-diagnosis
• Scleroderma per the ACR/EULAR 2013 classification criteria or physician-diagnosis
• New onset of Comorbid anxiety and/or depression
• Participants must speak English
• Participants must be able to attend a weekly (8 weeks total) Mindfulness Based Stress Reduction course as well as routine follow up appointments in the rheumatology clinic
• Participants must have insurance

You may not qualify if…

• Patients who routinely perform mindfulness based practices and any other form of meditation, including moving meditations such as yoga
• Patients who are not physically able to sit through weekly sessions that are 2.5 hours in length or a final meditative retreat of 4-hours duration
• Patients with alcohol or substance use disorders within the past 6 months
• Current, or previous history of psychotic disorders or bipolar disorder
• Patients who are actively suicidal
• Patients on greater than 10 mg of prednisone daily on a chronic basis.

Where it is running

• Johns Hopkins Asthma and Allergy Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.